Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Florian Lordick(Unknown), Dirk Arnold(University Medical Center Freiburg), C. Mariette(Hôpital Claude Huriez), Radka Obermannová(Masaryk University), Karin Haustermans(Radboud University Nijmegen)
Annals of Oncology
September 1, 2016
10.1093/annonc/mdw329
Cited by 1,117

Related Papers

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
|The Lancet|2010|7.3k
Gastric cancer
|The Lancet|2020|4.8k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
|JAMA|2010|1.4k
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2022|1.4k